Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas
Clinical trial NCT00782626 · COMPLETED
Trial details
- NCT number
- NCT00782626
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2012-08-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.